Vistra, a leading provider of expert advisory and administrative support to Private Equity and Venture Capital Fund, Corporate, Capital Market and Private Wealth clients, announces today a strategic partnership with the AMR Action Fund, the world’s largest public-private partnership supporting the development of new antibiotics. Vistra was chosen by the AMR Action Fund to provide fund administration and a multi-country, multi-service solution to enable them in their goal to bring 2 to 4 new antibiotics to market by the end of the decade.
The AMR Action Fund, a global venture capital fund, is an initiative of the international body representing the RD pharmaceutical industry (International Federation of Pharmaceutical Manufacturers Associations, IFPMA), in...
|